These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Control of bleeding after renal biopsy with epsilon-amino-caproic acid. Savdie E; Mahony JF; Storey BG Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206 [TBL] [Abstract][Full Text] [Related]
6. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial. Shucart WA; Hussain SK; Cooper PR J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206 [TBL] [Abstract][Full Text] [Related]
7. Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. Chowdhary UM; Sayed K J Neurol Neurosurg Psychiatry; 1981 Sep; 44(9):810-3. PubMed ID: 7031186 [TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. Markus G; DePasquale JL; Wissler FC J Biol Chem; 1978 Feb; 253(3):727-32. PubMed ID: 621200 [TBL] [Abstract][Full Text] [Related]
9. Effect of probenecid on the kinetics of epsilon-aminocaproic acid. Dvorchik BH; Katlic KL; Hayes AH; Eyster ME Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189 [TBL] [Abstract][Full Text] [Related]
11. The influence of epsilon-aminocaproic acid on the mineralocorticoid hypertension of the rat. Hartig F; Sponer G; Bartsch W; von Möllendorf E Exp Pathol; 1981; 19(4):199-205. PubMed ID: 7250299 [TBL] [Abstract][Full Text] [Related]
12. The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy. a review after 7 years. Smart CJ Br J Urol; 1982 Aug; 54(4):437. PubMed ID: 7116117 [No Abstract] [Full Text] [Related]
13. Inhibition of cold insolubility of an IgA cryoglobulin by decanedicarboxylic acid and related compounds. Lalezari P; Kumar M; Kumar KM; Lawrence C Am J Hematol; 1983 Nov; 15(3):279-88. PubMed ID: 6638013 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Frederiksen MC; Bowsher DJ; Ruo TI; Henthorn TK; Ts'ao CH; Green D; Atkinson AJ Clin Pharmacol Ther; 1984 Mar; 35(3):387-93. PubMed ID: 6697646 [TBL] [Abstract][Full Text] [Related]
15. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid. Chang JC; Kane KK Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732 [TBL] [Abstract][Full Text] [Related]
16. Comparison of epsilon aminocaproic acid and normal saline for postoperative bladder irrigation following transurethral resection of prostate. Flanigan RC; Butler KM; O'Neal W; Rapp RP; Casale AJ; Allen DC; McRoberts JW Urology; 1985 Sep; 26(3):227-8. PubMed ID: 3898514 [TBL] [Abstract][Full Text] [Related]
18. Hematuria after renal allograft biopsy: treatment with aminocaproic acid. Elliott SJ; Salcedo JR Urology; 1985 Jul; 26(1):20-1. PubMed ID: 3892850 [TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis. Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982 [TBL] [Abstract][Full Text] [Related]
20. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. Stefanini M; English HA; Taylor AE J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]